Gregory K. Bell, Andrew Tepperman, and Justin Ho contributed a chapter to Global Arbitration Review’s The Guide to Damages in International Arbitration. Their chapter, entitled “Damages in Life Sciences Arbitrations,” covers disputes in the life sciences sector, with a focus on the biopharmaceutical industry. The authors outline some of the main types of disputes that are heard in life sciences arbitrations and discuss some of the life sciences-specific aspects of common analyses that are used to determine damages in these types of disputes.
To read more, click the link below.
International Arbitration Update
In this update we are sharing a short summary of CRA’s recent engagements, publications, and speaking engagements involving International Arbitration. 2021 was...